Author
Gaby L. Longsworth, Ph.D. recently published an article for Bloomberg BNA’s Patent Trademark & Copyright Law Daily that discusses the use of Post-Grant Review in challenging biotech and pharma patents. Specifically, Ms. Longsworth highlights the unique advantages of PGR such as, short trial duration, broad classes of validity challenges, and the ability to settle and/or force claim amendments and why PGR is effective.
To read the full article, please see the attached PDF.
Related Industries
Related Services
Stay in the Know
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates